2
ABMD

2Xideas’s Abiomed Inc ABMD Stock Holding History

2Xideas’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,640
Closed -$9M – 75
2022
Q3 		$9M Sell
36,640
-3,830
-9% -$1.03M 0.95% 36
2022
Q2 		$10M Sell
40,470
-3,407
-8% -$919K 0.92% 48
2022
Q1 		$14.5M Sell
43,877
-452
-1% -$139K 1.03% 27
2021
Q4 		$15.9M Buy
44,329
+8,778
+25% +$2.97M 0.96% 32
2021
Q3 		$11.6M Buy
35,551
+6,181
+21% +$2.09M 0.88% 33
2021
Q2 		$9.17M Buy
29,370
+2,218
+8% +$680K 0.82% 58
2021
Q1 		$8.65M Buy
27,152
+4,766
+21% +$1.53M 0.96% 36
2020
Q4 		$7.26M Buy
+22,386
New +$6.19M 0.91% 28

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

2Xideas's ABMD Position: Q4 2022 in Review

2Xideas sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 36,640 shares — an estimated $9M sold.

2Xideas first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $15.9M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • 2Xideas reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • 2Xideas sold 36,640 Abiomed Inc shares in Q4 2022, an estimated $9M.
  • 2Xideas first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • 2Xideas's Abiomed Inc position peaked at $15.9M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on 2Xideas's 13F filing for Q4 2022, filed 14 Feb 2023.